UK Firms Partner to Develop Platform for Drug Discovery

Isogenica, Biolauncher, and Cresset Biomolecular Discovery will integrate expertise in peptide library design, evolutionary screening, next-generation sequencing, structural analysis, and molecular field-based computational chemistry into their new platform.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories